Aslam Akhtar

Title: Innovations in Neurotrophic Factor Delivery by Aslam Akhtar

Introduction

Aslam Akhtar is a prominent inventor based in Torrance, California. He has made significant contributions to the field of neurobiology, particularly in the delivery of neurotrophic factors for therapeutic purposes. His work aims to improve treatment options for neurodegenerative diseases such as Parkinson's and ALS.

Latest Patents

Aslam Akhtar holds a patent for "Methods and compositions for inducible expression of neurotrophic factors." This innovative approach addresses the challenges associated with chronic delivery of glial cell line-derived neurotrophic factor (GDNF). The patent describes a stably integrating, third-generation doxycycline-regulated vector that allows for the inducible and reversible expression of therapeutic molecules. This method has shown promise in preclinical trials, demonstrating the ability to modulate GDNF expression in vivo.

Career Highlights

Aslam Akhtar is affiliated with Cedars-Sinai Medical Center, where he conducts research focused on gene and stem cell therapy. His work has provided valuable insights into the modulation of ectopic protein expression in transplanted cells. The findings from his research have the potential to enhance treatment strategies for patients suffering from neurodegenerative conditions.

Collaborations

Aslam Akhtar has collaborated with notable researchers in his field, including Clive N Svendsen and Joshua Breunig. These collaborations have contributed to the advancement of knowledge in neurotrophic factor delivery and its applications in clinical settings.

Conclusion

Aslam Akhtar's innovative work in neurotrophic factor delivery represents a significant advancement in the treatment of neurodegenerative diseases. His contributions continue to pave the way for future research and therapeutic developments.